Progress on cell differentiation and clinical application in neuroblastoma / 国际儿科学杂志
International Journal of Pediatrics
; (6): 23-28, 2023.
Article
de Zh
| WPRIM
| ID: wpr-989030
Bibliothèque responsable:
WPRO
ABSTRACT
Neuroblastoma(NB)is the most common extracranial solid tumor in children.It is notable for highly heterogeneous and associated with tumor histologic classification and differentiation status, with ganglioneuroma representing fully mature and differentiated NB.Differentiation therapy reduces the adverse reactions caused by treatment without affecting normal cells and tissues by inducing the redifferentiation of NB cells, and has a good development prospect in the maintenance treatment of high-risk NB patients.Therefore, studying the key molecules and signaling pathways affecting NB differentiation is significant to further clarify the pathogenesis and improve the prognosis of neuroblastoma.This article reviews the important molecules related to NB cell differentiation, signaling pathways and the research progress of differentiation induction therapy.
Texte intégral:
1
Indice:
WPRIM
langue:
Zh
Texte intégral:
International Journal of Pediatrics
Année:
2023
Type:
Article